Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient

Hypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due to premature destruction of blood cells and normocellular bone marrow. Its etiology is diverse and includes (a) primary autoimmune cytopenias, (b) secondary to congestion due to portal hypertension in...

Full description

Bibliographic Details
Main Authors: Kamel El-Reshaid, Fahad Alabdulghani, Shaikha Al-Bader
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2021;volume=32;issue=1;spage=255;epage=260;aulast=El-Reshaid
_version_ 1818668018877595648
author Kamel El-Reshaid
Fahad Alabdulghani
Shaikha Al-Bader
author_facet Kamel El-Reshaid
Fahad Alabdulghani
Shaikha Al-Bader
author_sort Kamel El-Reshaid
collection DOAJ
description Hypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due to premature destruction of blood cells and normocellular bone marrow. Its etiology is diverse and includes (a) primary autoimmune cytopenias, (b) secondary to congestion due to portal hypertension in cirrhosis and, other causes such asperiportal fibrosis, infections, autoimmune diseases, lymphoproliferative disorders, infiltrative diseases and hemolytic anemias. The latter diseases are common in patients with end-stage kidney disease. In severe cases, co-existence of multiple co-morbid conditions, coagulopathy of uremia and dialysis-anticoagulation, and their immunosuppressive state render surgical splenectomy at highrisk. Mid-segment partial splenic infarction and with an aim at 50%–70% splenic volume loss was shown to be a less invasive therapy for HS. In our case report, we describe its first successful trial in a hemodialysis patient with severe HS due to cirrhosis.
first_indexed 2024-12-17T06:29:39Z
format Article
id doaj.art-c2668e66c5ed4616a38360c9f733028e
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-12-17T06:29:39Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-c2668e66c5ed4616a38360c9f733028e2022-12-21T22:00:11ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422021-01-0132125526010.4103/1319-2442.318535Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis PatientKamel El-ReshaidFahad AlabdulghaniShaikha Al-BaderHypersplenism (HS) is a disorder characterized by a triad of splenomegaly, peripheral cytopenia due to premature destruction of blood cells and normocellular bone marrow. Its etiology is diverse and includes (a) primary autoimmune cytopenias, (b) secondary to congestion due to portal hypertension in cirrhosis and, other causes such asperiportal fibrosis, infections, autoimmune diseases, lymphoproliferative disorders, infiltrative diseases and hemolytic anemias. The latter diseases are common in patients with end-stage kidney disease. In severe cases, co-existence of multiple co-morbid conditions, coagulopathy of uremia and dialysis-anticoagulation, and their immunosuppressive state render surgical splenectomy at highrisk. Mid-segment partial splenic infarction and with an aim at 50%–70% splenic volume loss was shown to be a less invasive therapy for HS. In our case report, we describe its first successful trial in a hemodialysis patient with severe HS due to cirrhosis.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2021;volume=32;issue=1;spage=255;epage=260;aulast=El-Reshaid
spellingShingle Kamel El-Reshaid
Fahad Alabdulghani
Shaikha Al-Bader
Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
Saudi Journal of Kidney Diseases and Transplantation
title Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
title_full Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
title_fullStr Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
title_full_unstemmed Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
title_short Partial Splenic Embolization for Hypersplenism Associated with Steatohepatitis in a Hemodialysis Patient
title_sort partial splenic embolization for hypersplenism associated with steatohepatitis in a hemodialysis patient
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2021;volume=32;issue=1;spage=255;epage=260;aulast=El-Reshaid
work_keys_str_mv AT kamelelreshaid partialsplenicembolizationforhypersplenismassociatedwithsteatohepatitisinahemodialysispatient
AT fahadalabdulghani partialsplenicembolizationforhypersplenismassociatedwithsteatohepatitisinahemodialysispatient
AT shaikhaalbader partialsplenicembolizationforhypersplenismassociatedwithsteatohepatitisinahemodialysispatient